Eko Health launches AI-enabled stethoscope

Digital cardiac and lung health company Eko Health has launched its FDA-cleared CORE 300 stethoscope for adult and pediatric patients, combining traditional listening with digital audio and access to AI-assisted murmur detection.

TeaWithNews Health 📅 October 23, 2026 ✍️ Editorial Team 3 min read

Eko Health has officially launched the CORE 300 digital stethoscope, an advanced AI-enabled device built specifically for point-of-care cardiac and pulmonary screening. This innovative medical tool bridges the gap between traditional acoustic auscultation and modern digital intelligence, empowering clinicians to detect subtle heart conditions with unprecedented speed and accuracy during routine patient examinations.

The device features up to 35x sound amplification alongside active noise cancellation, adjustable volume levels, and a shatter-resistant display that renders real-time heart rates and clear audio waveforms. Clinicians can easily toggle between standard unamplified listening and specialized digital modes designed for targeted cardiac, pulmonary, or comprehensive exams depending on immediate clinical needs.

Powered by FDA-cleared AI algorithms that sync seamlessly with the Eko mobile app, the stethoscope can flag structural heart murmurs, atrial fibrillation, and low ejection fraction within seconds. Backed by supportive clinical studies and equipped with multi-week battery life and USB-C fast charging, the CORE 300 is currently rolling out across the United States, Canada, the United Kingdom, and select European markets.